Exact Mass: 509.38687360000006

Exact Mass Matches: 509.38687360000006

Found 27 metabolites which its exact mass value is equals to given mass value 509.38687360000006, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

LysoPC(O-18:0)

(2-{[(2R)-2-hydroxy-3-(octadecyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

C26H56NO6P (509.3845046)


1-Octadecyl-sn-glycero-3-phosphocholine is an intermediate in the ether lipid metabolism pathway. 1-Octadecyl-sn-glycero-3-phosphocholine is irreversibly produced from 2-acetyl-1-(9Z-octadecenyl)-sn-glycero-3-phosphocholine via the enzyme 1-alkyl-2-acetylglycerophosphocholine esterase (EC 3.1.1.47). 1-Octadecyl-sn-glycero-3-phosphocholine is an ether phospho-ether lipid. Ether lipids are lipids in which one or more of the carbon atoms on glycerol are bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. 1-Octadecyl-sn-glycero-3-phosphocholine is an intermediate in the ether lipid metabolism pathway. 1-Octadecyl-sn-glycero-3-phosphocholine is irreversibly produced from 2-acetyl-1-(9Z-octadecenyl)-sn-glycero-3-phosphocholine via the enzyme 1-alkyl-2-acetylglycerophosphocholine esterase (EC 3.1.1.47). 1-Octadecyl-sn-glycero-3-phosphocholine is an ether phospho-ether lipid. Ether lipids are lipids in which one or more of the carbon atoms on glycerol are bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage.

   

Phosphatidylcholine lyso alkyl 18:0

Phosphatidylcholine lyso alkyl 18:0

C26H56NO6P (509.38450460000007)


   

cyclo (-Gly-L-Orn-L-Val-3-amino-12-methyltetradecanoyl-)|rhodopeptin C4

cyclo (-Gly-L-Orn-L-Val-3-amino-12-methyltetradecanoyl-)|rhodopeptin C4

C27H51N5O4 (509.39408460000004)


   

2-O-ethyl PAF C-16

1-O-hexadecyl-2-O-ethyl-sn-glyceryl-3-phosphorylcholine

C26H56NO6P (509.38450460000007)


   

PC(O-10:0/O-8:0)[U]

3,5,9-Trioxa-4-phosphanonadecan-1-aminium, 4-hydroxy-N,N,N-trimethyl-7-(octyloxy)-, inner salt, 4-oxide

C26H56NO6P (509.38450460000007)


   

PC(O-16:0/O-2:0)

3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 7-ethoxy-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (R)-

C26H56NO6P (509.38450460000007)


   

PC(O-16:0/O-2:0)[U]

3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 7-ethoxy-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide

C26H56NO6P (509.38450460000007)


   

PC(O-17:0/O-1:0)[U]

3,5,9-Trioxa-4-phosphahexacosan-1-aminium, 4-hydroxy-7-methoxy-N,N,N-trimethyl-, inner salt, 4-oxide

C26H56NO6P (509.38450460000007)


   

PC(O-2:0/O-16:0)[U]

3,5,8-Trioxa-4-phosphatetracosan-1-aminium, 7-(ethoxymethyl)-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide

C26H56NO6P (509.38450460000007)


   

PC(O-9:0/O-9:0)[U]

3,5,9-Trioxa-4-phosphaoctadecan-1-aminium, 4-hydroxy-N,N,N-trimethyl-7-(nonyloxy)-, inner salt, 4-oxide

C26H56NO6P (509.38450460000007)


   

Ro 14-8160

3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (R)-

C26H56NO6P (509.38450460000007)


   

PC(O-18:0/0:0)[S]

3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (S)-

C26H56NO6P (509.38450460000007)


   

Ro 14-0859

3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (1)-

C26H56NO6P (509.38450460000007)


   

Lyso-PAF c-18

1-O-Octadecyl-sn-glyceryl-3-phosphorylcholine

C26H56NO6P (509.38450460000007)


   

1-O-Hexadecyl-2-O-ethyl-SN-glycero-3-phosphorylcholine

1-O-Hexadecyl-2-O-ethyl-SN-glycero-3-phosphorylcholine

C26H56NO6P (509.38450460000007)


   

(3-Hydroxy-2-octadecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Hydroxy-2-octadecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C26H56NO6P (509.38450460000007)


   

1-O-Hexadecyl-2-O-ethyl-sn-glycero-3-phosphocholine

1-O-Hexadecyl-2-O-ethyl-sn-glycero-3-phosphocholine

C26H56NO6P (509.38450460000007)


   

2-Aminoethyl (3-henicosoxy-2-hydroxypropyl) hydrogen phosphate

2-Aminoethyl (3-henicosoxy-2-hydroxypropyl) hydrogen phosphate

C26H56NO6P (509.38450460000007)


   

(3Z,6Z,9Z,12Z,15Z)-N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]octadeca-3,6,9,12,15-pentaenamide

(3Z,6Z,9Z,12Z,15Z)-N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]octadeca-3,6,9,12,15-pentaenamide

C33H51NO3 (509.38687360000006)


   

1-octadecylglycero-3-phosphocholine

1-O-Octadecyl-sn-glycero-3-phosphocholine

C26H56NO6P (509.38450460000007)


A 1-alkylglycero-3-phosphocholine in which the alkyl group is specified as octadecyl.

   

LPE O-21:0

LPE O-21:0

C26H56NO6P (509.38450460000007)


   

Cer 15:3;O2/18:5

Cer 15:3;O2/18:5

C33H51NO3 (509.38687360000006)


   

(2-{[(2r)-2-hydroxy-3-(octadecyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

(2-{[(2r)-2-hydroxy-3-(octadecyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

C26H56NO6P (509.38450460000007)


   

6-(3-aminopropyl)-3-isopropyl-13-(9-methylundecyl)-1,4,7,10-tetraazacyclotrideca-1,4,7,10-tetraene-2,5,8,11-tetrol

6-(3-aminopropyl)-3-isopropyl-13-(9-methylundecyl)-1,4,7,10-tetraazacyclotrideca-1,4,7,10-tetraene-2,5,8,11-tetrol

C27H51N5O4 (509.39408460000004)


   

(3s,6s,13r)-6-(3-aminopropyl)-3-isopropyl-13-(9-methylundecyl)-1,4,7,10-tetraazacyclotrideca-1,4,7,10-tetraene-2,5,8,11-tetrol

(3s,6s,13r)-6-(3-aminopropyl)-3-isopropyl-13-(9-methylundecyl)-1,4,7,10-tetraazacyclotrideca-1,4,7,10-tetraene-2,5,8,11-tetrol

C27H51N5O4 (509.39408460000004)


   

(3s,6s)-6-(3-aminopropyl)-3-isopropyl-13-(9-methylundecyl)-1,4,7,10-tetraazacyclotrideca-1,4,7,10-tetraene-2,5,8,11-tetrol

(3s,6s)-6-(3-aminopropyl)-3-isopropyl-13-(9-methylundecyl)-1,4,7,10-tetraazacyclotrideca-1,4,7,10-tetraene-2,5,8,11-tetrol

C27H51N5O4 (509.39408460000004)


   

(3s,6s,9r)-13-heptyl-5,8,11-trihydroxy-3,6,9-tris(2-methylpropyl)-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one

(3s,6s,9r)-13-heptyl-5,8,11-trihydroxy-3,6,9-tris(2-methylpropyl)-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-2-one

C28H51N3O5 (509.38285160000004)